Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > CIDY vs THTX..

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Dec 21, 2020 4:07pm

130 Views

Post# 32154775

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CIDY vs THTX..

It's been said many times here, but they have been relegated to "Prove It" territory, so we need solid fundamental developments to underpin valuation. That should get it moving the right direction.

Definitely tax selling. I had some small below market orders at $2.10 that got hit toward end of day. A lot of times, they alot a certain number of shares a day and rush to meet them at the end.....and then start again tomorrow! We should only have another 7 trading days in the year so it's just about over.